- Home
- HELP vs AUTL Comparison
HELP vs AUTL Comparison
Compare HELP & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$6.14
HOLD
Current Price
$1.41
Company Overview
Basic Information| Metric | HELP | AUTL |
|---|---|---|
| Founded | N/A | 2014 |
| Country | Canada | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 375.7M | 433.8M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | HELP | AUTL |
|---|---|---|
| Price | $6.14 | $1.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.33 |
| AVG Volume (30 Days) | 476.5K | ★ 1.5M |
| Earning Date | 02-13-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $51,128,000.00 |
| Revenue This Year | N/A | $672.42 |
| Revenue Next Year | N/A | $84.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 406.67 |
| 52 Week Low | $4.81 | $1.11 |
| 52 Week High | $10.59 | $2.70 |
Technical Indicators
Market Signals| Indicator | HELP | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 39.12 | 47.94 |
| Support Level | $5.88 | $1.36 |
| Resistance Level | $6.65 | $1.48 |
| Average True Range (ATR) | 0.55 | 0.07 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 24.04 | 76.47 |
Price Performance
Historical Comparison HELP
AUTL
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.